A new study reveals a groundbreaking approach to immunotherapy, demonstrating that blocking the interaction between the CD300A receptor and phosphatidylserine (PS) significantly enhances the ability of human natural killer (NK) cells to lyse hematologic malignancies (HMs).
Cancer has a profound impact on human life, and immune checkpoint therapy (ICT) has made remarkable strides in cancer treatment. However, ICT faces challenges such as low overall response rates and the emergence of immune-related adverse events. To overcome these hurdles, researchers are exploring new immune checkpoints. CD300A, a type-I transmembrane protein with immunoreceptor tyrosine-based inhibitory motifs, emerges as a potential immune checkpoint, negatively regulating NK cell function through its interaction with PS.
In a recent study (DOI:10.20892/j.issn.2095-3941.2023.0341) published in Cancer Biology & Medicine, researchers from the University of Science and Technology of China have discovered a novel strategy to enhance the ability of human natural killer (NK) cells to combat hematologic malignancies. By blocking the CD300A protein, a type-I transmembrane protein with immunoreceptor tyrosine-based inhibitory motifs, the team demonstrated a significant boost in the lytic function of NK cells against cancer cells.
The study centered on the CD300A protein, a known immune checkpoint found on the surface of NK cells. The researchers discovered that when CD300A interacts with phosphatidylserine (PS), a molecule present on the surface of cancer cells, it dampens the NK cells' ability to attack and destroy these cells. To counteract this, the team developed a strategy to block CD300A using a specially designed monoclonal antibody called TX49. By doing so, they were able to enhance the NK cells' cytotoxic capabilities, making them more effective at lysing cancer cells both in vitro and in vivo. The study demonstrated that blocking CD300A not only increased the expression of proteins related to cell lysis but also the secretion of cytokines, which are crucial for immune response coordination. This approach led to a significant improvement in the survival rate of mice with xenografted human blood cancer cells, offering a promising therapeutic avenue for patients suffering from hematologic malignancies and potentially other types of cancer.
"By targeting CD300A, we can potentially enhance the anti-tumor function of NK cells," said Zhigang Tian, a lead researcher in the study. "This could open new avenues for treating hematologic malignancies and possibly other cancer types."
The research suggests that targeting CD300A could be a promising addition to immune checkpoint-based cancer immunotherapy. The ability to invigorate NK cell-based treatments against HMs offers new hope for patients with these challenging cancers. The findings also indicate that enhanced expression of CD300A is associated with shorter survival and a more "exhausted" phenotype of intratumoral NK cells in patients with HMs or solid tumors.
###
References
DOI
10.20892/j.issn.2095-3941.2023.0341
Original Source URL
https://doi.org/10.20892/j.issn.2095-3941.2023.0341
Funding information
This work was supported by the National Key R&D Program of China (2019YFA0508502/3 and 2021YFC2300604), the Natural Science Foundation of China (Reference numbers 82388201, 82241216, and 32270963), the Research Funds of Center for Advanced Interdisciplinary Science and Biomedicine of IHM (QYZD20220008), and the Anhui Key Research and Development Plan (Reference number 2023z04020011).
About Cancer Biology & Medicine
Cancer Biology & Medicine (CBM) is a peer-reviewed open-access journal sponsored by China Anti-cancer Association (CACA) and Tianjin Medical University Cancer Institute & Hospital. The journal monthly provides innovative and significant information on biological basis of cancer, cancer microenvironment, translational cancer research, and all aspects of clinical cancer research. The journal also publishes significant perspectives on indigenous cancer types in China. The journal is indexed in SCOPUS, MEDLINE and SCI (IF 5.5, 5 year IF 6.1), with all full texts freely visible to clinicians and researchers all over the world (http://www.ncbi.nlm.nih.gov/pmc/journals/2000/).
END
Supercharging immune cells to battle blood cancer: Breakthrough in cancer immunotherapy
2024-05-09
(Press-News.org)
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
Liberals and conservatives differ on climate change beliefs—but are relatively united in taking action
2024-05-09
The division between liberals and conservatives on both climate-change beliefs and related policy support is long-standing. However, the results of a newly released global experiment show that despite these differences, the two camps actually align when it comes to taking certain actions to combat climate change.
The study, led by researchers at New York University, finds that when given the opportunity, liberals and conservatives take action to address climate change at roughly the same levels—and that ...
Biogeographical evidence shows trickster animal folklore limited by environmental factors
2024-05-09
Humans have the capacity to imagine civilizations and creatures that have never existed, and our language reflects that ability. It would therefore be understandable if the stories we tell ourselves stretched beyond the bounds of local ecology. However, research has shown that many cultural artifacts and ideas are strongly affected by environmental factors.
Researchers in Japan wanted to know if the biogeography of a region could constrain motifs in animal folklore. To do this, they studied the distribution of animal trickster folklore against the distribution of the animal the folklore ...
Researchers harness blurred light to 3D print high quality optical components
2024-05-09
WASHINGTON — Canadian researchers have developed a new 3D printing method called blurred tomography that can rapidly produce microlenses with commercial-level optical quality. The new method may make it easier and faster to design and fabricate a variety of optical devices.
“We purposely added optical blurring to the beams of light used for this 3D printing method to manufacture precision optical components,” said Daniel Webber from the National Research Council of Canada. “This enables production of optically smooth surfaces.”
In Optica, Optica Publishing Group’s journal for high-impact research, these researchers demonstrate the new method by using ...
Older adults with aggressive blood cancer are responsive to treatment and show prolonged survival
2024-05-09
(WASHINGTON, May 9, 2024) – Standard of care treatment for acute myeloid leukemia (AML) is safe and effective for adults over 80, according to a study published in Blood Neoplasia. For roughly a quarter of patients, this treatment can durably prolong survival.
AML is an aggressive and often deadly form of blood cancer that can be difficult to treat. For older adults with AML, the conventional treatment consists of a medication called venetoclax combined with a hypomethylating agent (HMA), also known as VEN-HMA. AML treatment is often intensive and can significantly suppress the immune system ...
Redesigning healthcare: Integrating social care into a safety net health system
2024-05-09
INDIANAPOLIS -- Neighborhoods of high need are where investment in social care offers the best opportunities to improve health. Screening for social determinants of health is comparatively easy, but building the infrastructure to meet needs occurring outside the formal healthcare system is quite difficult. Few health systems have achieved more than even partial integration of social care into routine patient care.
In a case study of pioneering social care provided by Eskenazi Health, a safety net health system located in Indianapolis, ...
Discovery made into which children will outgrow their peanut allergy
2024-05-09
Australian researchers have discovered how changes in antibody levels over time can predict which children are likely to outgrow their peanut allergy.
The research, led by Murdoch Children’s Research Institute (MCRI) in Melbourne and published in Allergy, found two thirds of children with a peanut allergy remain allergic by the age of 10. But for those who did naturally outgrow their allergy, the majority achieved this by six years old.
The study was the first to use antibodies as biomarkers to identify persistent or a resolved ...
Princeton physicists reveal the microscopic basis of a new form of quantum magnetism
2024-05-09
By Tom Garlinghouse for the Princeton University Department of Physics
Not all magnets are the same. When we think of magnetism, we often think of magnets that stick to a refrigerator’s door. For these types of magnets, the electronic interactions that give rise to magnetism have been understood for around a century, since the early days of quantum mechanics. But there are many different forms of magnetism in nature, and scientists are still discovering the mechanisms that drive them.
Now, physicists ...
Oikopleura who? Species identity crisis in the genome community
2024-05-09
When two animals look the same, eat the same, behave the same way, and live in similar environments, one might expect that they belong to the same species.
However, a tiny zooplankton skimming the ocean surfaces of microscopic food particles challenges this assumption. Researchers from Osaka University, University of Barcelona and the Okinawa Institute of Science and Technology (OIST) have analyzed the genome of Oikopleura dioica from the Seto Inland Sea, the Mediterranean, and the Pacific Ocean around the Okinawa Islands, and in doing so, they have raised numerous questions about speciation and the role of gene location in ...
Developed compiler acceleration technology for quantum computers
2024-05-09
[Highlights]
- Developed a new compilation method to generate optimal sequences to be executed on quantum computers
- The new method is based on a probabilistic approach and reduces the time to search for the optimal sequence by several orders of magnitude.
- Expected to contribute to quantum information processing at quantum nodes that support the quantum internet
[Abstract]
The National Institute of Information and Communications Technology (NICT, President: TOKUDA Hideyuki, Ph.D.), RIKEN (President: GONOKAMI Makoto, Ph.D.), Tokyo University of Science (President: Dr. ISHIKAWA Masatoshi), and the University of Tokyo (President: FUJII Teruo, Ph.D.) succeeded ...
Report: Governments falling short on promises of effective biodiversity protection
2024-05-09
WASHINGTON— A new analysis of the world’s largest 100 marine protected areas (MPAs) published today in Conservation Letters suggests that governments are falling short on delivering the promise of effective biodiversity protection due to slow implementation of management strategies and failure to restrict the most impactful activities.
The assessment, titled “Ocean protection quality is lagging behind quantity: Applying a scientific framework to assess real marine protected area progress ...